Načítá se...
Issues in assessing products for the treatment of hemophilia – the intersection between efficacy, economics, and ethics
Following the obviation of the pathogen safety threats posed by previous generations of clotting factor concentrates for the treatment of hemophilia, the principal issue facing the patient community is timely access to adequate supplies of continuously improving therapies. The application of evidenc...
Uloženo v:
| Vydáno v: | J Blood Med |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4476485/ https://ncbi.nlm.nih.gov/pubmed/26124687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S79091 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|